Evidence map›Paper›PMID 27669692›Full record

ReviewCellular and molecular life sciences : CMLS2017

Profilin1 biology and its mutation, actin(g) in disease.

Duah Alkam, Ezra Z Feldman, Awantika Singh, Mahmoud Kiaei

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 119 citations in OpenAlex.

  1. Biomarkers of tumor invasiveness in proteomics (Review).International journal of oncology · 2020
    Pooled it
  2. Profilin-1 Promotes Chromophobe Renal Cell Carcinoma Malignancy.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Duah AlkamDepartment of Pharmacology and Toxicology, The University of Arkansas for Medical Sciences, Little Rock, AR, 72223, USA.
Ezra Z FeldmanDepartment of Pharmacology and Toxicology, The University of Arkansas for Medical Sciences, Little Rock, AR, 72223, USA.
Awantika SinghDepartment of Pharmacology and Toxicology, The University of Arkansas for Medical Sciences, Little Rock, AR, 72223, USA.
Mahmoud KiaeiDepartment of Pharmacology and Toxicology, The University of Arkansas for Medical Sciences, Little Rock, AR, 72223, USA. mkiaei@uams.edu.
University of Arkansas for Medical Sciences · US

Funding

Telemedicine CoreP30GM110702 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI GARCIA-RILL, EDGAR E. · 2014 to 2018
$6.1M
Development of a New ALS Mouse Model that Targets Profilin1 and Actin FilamentsR21NS088653 · NINDS · UNIV OF ARKANSAS FOR MED SCIS · PI KIAEI, MAHMOUD · 2015 to 2016
$410k
NIGMS NIH HHS P30 GM110702NINDS NIH HHS R21 NS088653
6 · The paper itself

Abstract

Profilins were discovered in the 1970s and were extensively studied for their significant physiological roles. Profilin1 is the most prominent isoform and has drawn special attention due to its role in the cytoskeleton, cell signaling, and its link to conditions such as cancer and vascular hypertrophy. Recently, multiple mutations in the profilin1 gene were linked to amyotrophic lateral sclerosis (ALS). In this review, we will discuss the physiological and pathological roles of profilin1. We will further highlight the cytoskeletal function and dysfunction caused by profilin1 dysregulation. Finally, we will discuss the implications of mutant profilin1 in various diseases with an emphasis on its contribution to the pathogenesis of ALS.

Indexed as

ActinsAnimalsBrainDiseaseHumansMutationNeuronal PlasticityProfilinsActinsProfilinsActin-binding domainAxonal dynamicsMotor neuron diseaseNeurodegenerationPFN1 aggregationPFN1G118VPFN1 instabilityPLP domainPolymerization

Identifiers

PMID27669692
PMCPMC5311022
OpenAlexW2524518321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.